Skip to main content
Completed Clinical Trials

Mesothelioma Avastin Plus Pemetrexed-cisplatin Study

By April 24, 2017No Comments

Condition

Mesothelioma

Estimated Enrollment: 448

Age Group: 18 Years to 75 Years   (Adult, Senior)

Gender: All

Study Type: Interventional

Study Design Allocation: Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Open Label|Primary Purpose: Treatment

Study ID Numbers: IFCT-GFPC-0701

Study First Received: March 29, 2008

Last Updated: September 1, 2016

Estimated Primary Completion Date: January 2015

 

Primary Outcome Measures:

% of patients with controled disease (responder and stable patients) at 6 months|Overall Survival|Number of participants with treatment-related adverse events as assessed by CTCAE v3.0

Sponsors and Collaborators:

Intergroupe Francophone de Cancerologie Thoracique|University Hospital, Caen|Groupe Francais De Pneumo-Cancerologie

Website Link: https://ClinicalTrials.gov/show/NCT00651456

Leave a Reply